The NF-κB pathway, when activated by hyperglycemia-induced insulin resistance, leads to the production of pro-inflammatory cytokines and mediators in microglia alongside an increase in reactive oxygen species (ROS), impairing mitochondrial function and inducing neuronal damage [122]. The gene discussed is NFKB1; the disease is Insulin resistance.